Terms: = Liver cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721
1672 results:
1. Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software.
Ali E; Červenková L; Pálek R; Ambrozkiewicz F; Pavlov S; Ye W; Hošek P; Daum O; Liška V; Hemminki K; Trailin A
J Vis Exp; 2024 Apr; (206):. PubMed ID: 38682951
[TBL] [Abstract] [Full Text] [Related]
2. Activation of the MEK/ERK Pathway Mediates the Inhibitory Effects of Silvestrol on Nasopharyngeal Carcinoma Cells via RAP1A, HK2, and GADD45A.
Yu LR; Han XZ; Tang YZ; Liu D; Luo XQ; Qiu XW; Feng J; Yuan WX; Ding JY
Front Biosci (Landmark Ed); 2024 Apr; 29(4):160. PubMed ID: 38682208
[TBL] [Abstract] [Full Text] [Related]
3. Epithelial-Mesenchymal Transformation Promotes the Progression of Hepatocellular Carcinoma through NF-κB/MMP9 Axis.
Li J; Cai Q; Wang Z; Wang L; Yang G; Zhang Z; Ge N; Hu S; Bai T
Discov Med; 2024 Apr; 36(183):666-677. PubMed ID: 38665016
[TBL] [Abstract] [Full Text] [Related]
4. [Baicalin induces ferroptosis in HepG2 cells by inhibiting ROS-mediated PI3K/Akt/FoxO3a signaling pathway].
Zhou JQ; Li HJ; Zeng YH; Chen HH; Liang WY; Zhang J; Ding FP
Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(5):1327-1334. PubMed ID: 38621980
[TBL] [Abstract] [Full Text] [Related]
5. [Bupleuri Radix-Paeoniae Radix Alba medicated plasma exerts effects on HepG2 hepatoma cells by regulating miR-1297/PTEN signaling axis].
Ding L; Wang RY; Zhang F; Wu MS; Chen B; Sun KW
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):1073-1081. PubMed ID: 38621914
[TBL] [Abstract] [Full Text] [Related]
6. TDF and TAF inhibit liver cancer cell migration, invasion via p7TP3.
Zhao J; Zhou L; Zhang Y; Cheng J; Zeng Y; Li X
Sci Rep; 2024 Apr; 14(1):8161. PubMed ID: 38589540
[TBL] [Abstract] [Full Text] [Related]
7. CircSNX6 promotes proliferation, metastasis, and angiogenesis in hepatocellular carcinoma via miR-383-5p/VEGFA signaling pathway.
Tian Y; Han W; Lv K; Fu L; Zhou X
Sci Rep; 2024 Apr; 14(1):8243. PubMed ID: 38589413
[TBL] [Abstract] [Full Text] [Related]
8. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
[TBL] [Abstract] [Full Text] [Related]
9. Sarcomatoid hepatocellular carcinoma: A case report and review of the literature.
Hu C; Zhao M; Wei Q; Chen Z; Zhao B
Medicine (Baltimore); 2024 Mar; 103(13):e37641. PubMed ID: 38552058
[TBL] [Abstract] [Full Text] [Related]
10. Fibroblast activation protein promotes progression of hepatocellular carcinoma via regulating the immunity.
Wang X; Niu R; Yang H; Lin Y; Hou H; Yang H
Cell Biol Int; 2024 May; 48(5):577-593. PubMed ID: 38501437
[TBL] [Abstract] [Full Text] [Related]
11. Clinical significance of small nuclear ribonucleoprotein U1 subunit 70 in patients with hepatocellular carcinoma.
Jiang D; Zhu XL; An Y; Li YR
PeerJ; 2024; 12():e16876. PubMed ID: 38500533
[TBL] [Abstract] [Full Text] [Related]
12. Improvement of hepatic innate immunity in chemically-injured livers to develop hepatocarcinoma by a serine type-protease inhibitors enriched extract from
Rueda Huélamo MA; Martínez Perlado A; Consoli V; García-Tejedor A; Haros CM; Laparra Llopis JM
Food Funct; 2024 Apr; 15(7):3600-3614. PubMed ID: 38469889
[TBL] [Abstract] [Full Text] [Related]
13. Routine evaluation of HBV-specific T cell reactivity in chronic hepatitis B using a broad-spectrum T-cell epitope peptide library and ELISpot assay.
Wu Y; Liu X; Mao Y; Ji R; Xia L; Zhou Z; Ding Y; Li P; Zhao Y; Peng M; Qiu J; Shen C
J Transl Med; 2024 Mar; 22(1):266. PubMed ID: 38468254
[TBL] [Abstract] [Full Text] [Related]
14. Extracellular vesicles from
Meng X; Ma G; Zhang X; Yin H; Miao Y; He F
Cell Cycle; 2024 Feb; 23(3):294-307. PubMed ID: 38446489
[TBL] [Abstract] [Full Text] [Related]
15. Inhibition of UBA52 induces autophagy via EMC6 to suppress hepatocellular carcinoma tumorigenesis and progression.
Tong L; Zheng X; Wang T; Gu W; Shen T; Yuan W; Wang S; Xing S; Liu X; Zhang C; Zhang C
J Cell Mol Med; 2024 Mar; 28(6):e18164. PubMed ID: 38445807
[TBL] [Abstract] [Full Text] [Related]
16. Extramedullary hematopoiesis in cancer.
Barisas DAG; Choi K
Exp Mol Med; 2024 Mar; 56(3):549-558. PubMed ID: 38443597
[TBL] [Abstract] [Full Text] [Related]
17. Cucurbitacin IIa promotes the immunogenic cell death‑inducing effect of doxorubicin and modulates immune microenvironment in liver cancer.
Li S; Wang S; Zhang A; Luo L; Song J; Wei G; Fang Z
Int J Oncol; 2024 Apr; 64(4):. PubMed ID: 38391053
[TBL] [Abstract] [Full Text] [Related]
18. USP14 exhibits high expression levels in hepatocellular carcinoma and plays a crucial role in promoting the growth of liver cancer cells through the HK2/AKT/P62 axis.
Zhang N; Zhang H; Yang X; Xue Q; Wang Q; Chang R; Zhu L; Chen Z; Liu X
BMC Cancer; 2024 Feb; 24(1):237. PubMed ID: 38383348
[TBL] [Abstract] [Full Text] [Related]
19. Hsa_circ_0005397 promotes hepatocellular carcinoma progression through EIF4A3.
Yuan LX; Luo M; Liu RY; Wang HX; Ju LL; Wang F; Cao YL; Wang ZC; Chen L
BMC Cancer; 2024 Feb; 24(1):239. PubMed ID: 38383334
[TBL] [Abstract] [Full Text] [Related]
20. Spectrum-effect relationship study between ultra-high-performance liquid chromatography fingerprints and anti-hepatoma effect in vitro of Cnidii Fructus.
Lv Z; Ouyang H; Zuo F; Ge M; Wu M; Zhao L; Zhu Y; Miao X; Bai Y; Chang Y; He J
Biomed Chromatogr; 2024 May; 38(5):e5847. PubMed ID: 38368628
[TBL] [Abstract] [Full Text] [Related]
[Next]